Pages that link to "Q29614276"
Jump to navigation
Jump to search
The following pages link to A perivascular niche for brain tumor stem cells (Q29614276):
Displaying 50 items.
- Salinomycin as a drug for targeting human cancer stem cells (Q21285139) (← links)
- Dual Inhibitor AEE788 Reduces Tumor Growth in Preclinical Models of Medulloblastoma (Q24615472) (← links)
- PLAGL2 regulates Wnt signaling to impede differentiation in neural stem cells and gliomas (Q24615768) (← links)
- Hypoxia-Inducible Factors and the Response to Hypoxic Stress (Q24629323) (← links)
- Tumor initiation in human malignant melanoma and potential cancer therapies (Q24634207) (← links)
- Human embryonic and neuronal stem cell markers in retinoblastoma (Q24647640) (← links)
- Tumor-endothelial interaction links the CD44(+)/CD24(-) phenotype with poor prognosis in early-stage breast cancer (Q24652733) (← links)
- Expression of mutant p53 proteins implicates a lineage relationship between neural stem cells and malignant astrocytic glioma in a murine model (Q24656542) (← links)
- New chemotherapy strategies and biological agents in the treatment of childhood ependymoma (Q24658324) (← links)
- Tumor refractoriness to anti-VEGF therapy (Q26747678) (← links)
- The NF-κB Pathway and Cancer Stem Cells (Q26750605) (← links)
- Glioma Stem Cells and Their Microenvironments: Providers of Challenging Therapeutic Targets (Q26765758) (← links)
- Glioma Stem Cells: Signaling, Microenvironment, and Therapy (Q26765854) (← links)
- Glioblastoma Stem Cells Microenvironment: The Paracrine Roles of the Niche in Drug and Radioresistance (Q26765869) (← links)
- Epigenetic modulators, modifiers and mediators in cancer aetiology and progression (Q26766149) (← links)
- Effects of Charged Particles on Human Tumor Cells (Q26767252) (← links)
- Cancer Stem Cells and Their Interaction with the Tumor Microenvironment in Neuroblastoma (Q26771238) (← links)
- Cancer stem cell-vascular endothelial cell interactions in glioblastoma (Q26773998) (← links)
- Cancer stem cell targeted therapy: progress amid controversies. (Q26779931) (← links)
- Therapeutic strategies targeting cancer stem cells (Q26781398) (← links)
- Differentiation and transdifferentiation potentials of cancer stem cells (Q26782242) (← links)
- Intra-tumor heterogeneity of cancer cells and its implications for cancer treatment (Q26783055) (← links)
- Cancer stem cells and the tumor microenvironment: interplay in tumor heterogeneity (Q26796292) (← links)
- Mesenchymal stem cells secretome as a modulator of the neurogenic niche: basic insights and therapeutic opportunities (Q26799013) (← links)
- Targeting Aggressive Cancer Stem Cells in Glioblastoma (Q26799983) (← links)
- The evolution of endothelial regulatory paradigms in cancer biology and vascular repair (Q26822678) (← links)
- Cancer stem cells--important players in tumor therapy resistance (Q26823015) (← links)
- Lung cancer-initiating cells: a novel target for cancer therapy (Q26824222) (← links)
- Epithelial-mesenchymal plasticity of breast cancer stem cells: implications for metastasis and therapeutic resistance (Q26824386) (← links)
- Mechanisms of neovascularization and resistance to anti-angiogenic therapies in glioblastoma multiforme (Q26824557) (← links)
- Cancer heterogeneity--a multifaceted view (Q26829228) (← links)
- The three-layer concentric model of glioblastoma: cancer stem cells, microenvironmental regulation, and therapeutic implications (Q26829663) (← links)
- Twisted tango: brain tumor neurovascular interactions (Q26849613) (← links)
- EGFR Amplification and Glioblastoma Stem-Like Cells (Q26853549) (← links)
- Understanding glioma stem cells: rationale, clinical relevance and therapeutic strategies (Q26995698) (← links)
- Cancer stem cells, epithelial-mesenchymal transition, and drug resistance in high-grade ovarian serous carcinoma (Q26998068) (← links)
- Brain tumor stem cells: Molecular characteristics and their impact on therapy (Q27003138) (← links)
- The potential origin of glioblastoma initiating cells (Q27005807) (← links)
- Novel delivery strategies for glioblastoma (Q27006099) (← links)
- Antibody, T-cell and dendritic cell immunotherapy for malignant brain tumors (Q27011298) (← links)
- Mechanisms of evasive resistance to anti-VEGF therapy in glioblastoma (Q27021470) (← links)
- Molecular pathways: not a simple tube--the many functions of blood vessels (Q27025036) (← links)
- Long-term temozolomide might be an optimal choice for patient with multifocal glioblastoma, especially with deep-seated structure involvement: a case report and literature review (Q27026704) (← links)
- Targeting glioma stem cells: a novel framework for brain tumors (Q27026818) (← links)
- Short-Term Differentiation of Glioblastoma Stem Cells Induces Hypoxia Tolerance (Q27314916) (← links)
- MiR-34a targeting of Notch ligand delta-like 1 impairs CD15+/CD133+ tumor-propagating cells and supports neural differentiation in medulloblastoma (Q27320938) (← links)
- Establishment and Characterization of a Tumor Stem Cell-Based Glioblastoma Invasion Model (Q27333230) (← links)
- Modeling evolutionary dynamics of epigenetic mutations in hierarchically organized tumors (Q27333860) (← links)
- Targeting the biophysical properties of the myeloma initiating cell niches: a pharmaceutical synergism analysis using multi-scale agent-based modeling (Q27334339) (← links)
- Cellular microenvironment modulates the galvanotaxis of brain tumor initiating cells (Q27346530) (← links)